Sun Pharma Announces Q4 and Full Year Results for FY26, Highlights 13.6% Q4 Sales Growth
Mumbai, May 22, 2026 – Sun Pharmaceutical Industries Limited today announced its consolidated financial results for the fourth quarter ending March 31, 2026, and the full financial year 2026. The results reflect continued growth, with the company reporting sales of Rs. 145,598 million in Q4FY26, marking a 13.6% year-over-year increase.The company's full-year performance for FY26 saw total sales reach Rs. 582,201 million, representing an 11.9% growth compared to the previous year. Net profit after tax (PAT) was recorded at Rs. 114,794 million, achieving a 5.0% increase year-over-year.Innovative Medicines Drive Growth
A key growth driver was the...